Disruptive mood dysregulation disorder and pediatric bipolar disorder: diagnostic and prescribing trends following DSM-5
European Child & Adolescent Psychiatry · 2026
DOI: 10.1007/s00787-026-03097-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Child & Adolescent Psychiatry, 2026. Verfasst von Ching-Fang Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, 6901 Sandpoint Way NE, Seattle, WA, 98115, USA. chingf…. Hauptthemen laut MEDLINE: Bipolar Disorder, Diagnostic and Statistical Manual of Mental Disorders, Practice Patterns, Physicians', Mood Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Disruptive mood dysregulation disorder (DMDD) was introduced in DSM-5 in 2013 to address concerns about overdiagnosis of pediatric bipolar disorder in chronically irritable children. We examined population-level trends in DMDD and bipolar disorder diagnoses and psychotropic medication use in youth. We conducted an interrupted time-series analysis using electronic health record data from the TriNetX Global Collaborative Network spanning 2003-2025. Annual incidence rates were estimated for DMDD diagnosis, bipolar disorder diagnosis, antipsychotic prescribing, and mood stabilizer prescribing among patients aged 6-18 years. Segmented regression models were used to evaluate trends before and after the introduction of DMDD. Secondary analyses identified data-driven change points independent of the DSM-5 timeline. Following DMDD introduction, DMDD diagnoses increased steadily while bipolar disorder diagnoses declined. Antipsychotic and mood stabilizer prescribing did not show immediate changes and declined later in the study period. Data-driven analyses identified a change point in bipolar disorder diagnoses in 2009, several years before DMDD introduction, whereas prescribing change points occurred around 2021. Diagnostic and prescribing trends were therefore temporally dissociated. Changes in pediatric bipolar disorder diagnoses were not immediately associated with changes in psychotropic prescribing. The decline in bipolar diagnoses most likely reflects accumulating evidence against the validity of broad bipolar diagnoses in chronically irritable children, rather than a direct effect of DMDD's introduction. Changes in diagnostic labels do not automatically translate into changes in prescribing behaviors. Diagnostic trends should be interpreted with caution, particularly when the validity of the diagnostic categories themselves remains unclear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, 6901 Sandpoint Way NE, Seattle, WA, 98115, USA. chingfangsun@gmail.com.
- Department of Psychiatry, Children's Hospital and Regional Medical Center, Seattle, WA, USA. chingfangsun@gmail.com.
- Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
- Northwell, New Hyde Park, NY, USA.
- Department of Child and Adolescent Psychiatry, Universitätsmedizin Charité Berlin, Berlin, Germany.
- German Center for Mental Health (DZPG), partner site Berlin, Berlin, Germany.
Zitieren
APA
Sun, C. F., Correll, C. U., Wei, C. Y., & Kim, S. J. (2026). Disruptive mood dysregulation disorder and pediatric bipolar disorder: diagnostic and prescribing trends following DSM-5. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-026-03097-1
Vancouver
Sun CF, Correll CU, Wei CY, Kim SJ. Disruptive mood dysregulation disorder and pediatric bipolar disorder: diagnostic and prescribing trends following DSM-5. European Child & Adolescent Psychiatry. 2026. doi:10.1007/s00787-026-03097-1
BibTeX
@article{Sun2026,
author = {Sun, Ching-Fang and Correll, Christoph U and Wei, Chen-Yu and Kim, Soo-Jeong},
title = {Disruptive mood dysregulation disorder and pediatric bipolar disorder: diagnostic and prescribing trends following DSM-5},
journal = {European Child & Adolescent Psychiatry},
year = {2026},
doi = {10.1007/s00787-026-03097-1}
}
EUVIMED